Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease
1 other identifier
interventional
300
1 country
1
Brief Summary
The investigators conducted a prospective multi-center study assessing the effect of direct bypass and indrect bypass in treatment of hemorrhagic moyamoya disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 20, 2016
CompletedFirst Posted
Study publicly available on registry
December 5, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedDecember 5, 2016
November 1, 2016
1.9 years
November 20, 2016
December 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
rebleeding events
5-10 years
Secondary Outcomes (2)
ischemic events
5-10 years
postoperative compilications
30 days
Study Arms (2)
group 1 direct bypass
OTHERdirect bypass : patients recieve direct bypass treatment
group 2 indirect bypass
OTHERindirect bypass: patients recieve indirect bypass treatment
Interventions
bypass surgery : patients recieved STA-MCA bypass indrect bypass surgery:patients recieved EDAS or mutiple bur holes
Eligibility Criteria
You may qualify if:
- cerebral digital subtraction contrast angiography (DSA) revealed severe stenosis or occlusion of the distal internal carotid or proximal middle and anterior cerebral arteries with prominent lenticulostriate "moyamoya collaterals"
- patients had experienced at least one intracranial hemorrhage which was verified by computed tomography (CT) scanning, magnetic resonance imaging MRI), or lumbar puncture.
- Patients requiring surgery
You may not qualify if:
- Patient whose initial onset was marked by ischemia but subsequently suffered from intracranial hemorrhage
- patients refused to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- liuxingjulead
Study Sites (1)
Beijing Tiantan Hospital Capital Medical University
Beijing, Beijing Municipality, 0086, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 20, 2016
First Posted
December 5, 2016
Study Start
January 1, 2016
Primary Completion
December 1, 2017
Study Completion
January 1, 2018
Last Updated
December 5, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will share